CYTOO coordinates FP7 MEHTRICS involving CENIX, Bioquant, EPFL, CPST and Vitamib

CYTOO announces new public-private consortium to further develop the power of high throughput, high content RNAi screening through convergence with micropatterning-based cell assays.